---
title: "DC 7343 - Malignant neoplasms of the digestive system, exclusive of skin growths"
diagnostic_code: "7343"
body_system: "Digestive System"
cfr_section: "§ 4.114"
canonical: "https://veteranai.co/va-rating-schedule/digestive/7343-malignant-neoplasms-of-the-digestive-system-exclusive-of"
source: "https://www.ecfr.gov/current/title-38/section-4.114"
updated: "2026-07-21T04:18:31.176164Z"
---

# DC 7343 - Malignant neoplasms of the digestive system, exclusive of skin growths

Rated under § 4.114. Body system: Digestive System.

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | Malignant neoplasms of the digestive system, exclusive of skin growths |

## Notes

- Note: A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals.

# Malignant Neoplasms of the Digestive System (VA Diagnostic Code 7343)

*Body System: Digestive System · Rated under 38 CFR § 4.114*

## What This Condition Is

Diagnostic Code 7343 covers **malignant neoplasms (cancers) of the digestive system**, excluding skin growths. This category addresses cancers affecting the organs and structures involved in digestion.

## Available Rating Level

Under this diagnostic code, there is a single scheduled rating level:

| Rating | Criteria |
|--------|----------|
| **100%** | Malignant neoplasms of the digestive system, exclusive of skin growths |

## What the VA Looks For

- A **100 percent rating** applies to a malignant neoplasm of the digestive system (excluding skin growths).

- **This 100 percent rating continues** beyond the end of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure.

- **Six months after** such treatment is discontinued, the appropriate disability rating is determined by a **mandatory VA examination**.

- Any change in evaluation based on that examination — or any subsequent examination — is subject to the provisions of **§ 3.105(e)**.

- **If there has been no local recurrence or metastasis**, the condition is rated based on its residuals.

---

*This information is drawn directly from the VA rating schedule (38 CFR § 4.114, Diagnostic Code 7343). It is provided for general informational purposes and does not guarantee any particular rating outcome.*

Source: https://www.ecfr.gov/current/title-38/section-4.114